Why Invest in Next-Generation Sequencing (NGS)?

The COVID-19 pandemic has shone new light on the importance of genomic sequencing in understanding pathogens and controlling the spread of disease. Harnessing the transformative power of this technology, including in response to SARS-CoV-2, requires the active engagement from a broad spectrum of stakeholders, from ASM members working in research laboratories, academic medical centers, hospitals and clinical microbiology laboratories, industry partners and public health labs. Supporting and advancing pathogen genomics surveillance and sequencing across the field is a top priority for ASM.

What ASM Is Doing

Updates With the CDC

COVID-19 Variants and Next Steps for Pathogen Genomic Sequencing and Surveillance, with CDC's Greg Armstrong and former ASM President Susie Sharp

Previous Updates

World Microbe Forum Update (June 2021)
Feb 2021 Update
June 2020 Update

Estimates of SARS-CoV-2 Variant Prevalence in the U.S.

Data Visualization Source: CDC.

Hear From Experts


This Week in Virology: 2/21/21

The entire TWiV team assembles to discuss resurgence of COVID-19 in Manaus, Brazil, discovery of SARS-CoV-2 related viruses in bats in Southeast Asia and increased Ct values after administration of mRNA vaccine.

Scientific Publications

  • Search for articles about AMD in ASM Journals.
  • ASM's COVID-19 Research Registry was designed for the scientific research community to serve as a trusted source for credible science about COVID-19 and coronaviruses, in general.  Over 30,000 visitors have accessed the registry which includes a growing number of carefully-reviewed published and pre-print articles.


ASM hosted a symposium on clinical metagenomics for infectious disease at World Microbe Forum 2021.

Most recent ASM stories